Skip to main content
Year archive

Biotest AG — 2014 filings

All 42 regulatory filings released by Biotest AG (BIO3) in 2014, sourced directly from the official regulator.

42 Filings
2014 Period
2014 filings (42)
Filing Released Lang
Biotest AG: Encouraging Efficacy of Indatuximab Ravtansine (BT-062) in Multiple Myeloma in combination with Lenalidomide and Dexamethasone
Earnings Release FY 2014
2014-12-09 English
Biotest AG: Biotest Presents New Preclinical Data on Tregalizumab (BT-061) at the Annual
Regulatory Filings
2014-11-18 English
Q3 Report 2014
Interim / Quarterly Report 9M 2014
2014-11-18 German
Biotest AG: Managers of Italian Subsidiary have been charged with illegal price fixing
Legal Proceedings Report
2014-11-17 English
Biotest AG: Biotest increases sales by 11,5% compared to previous yea
Earnings Release 9M 2014
2014-11-12 English
Investor Presentation 2014
Investor Presentation 9M 2014
2014-11-12 German
Investor Presentation 2014
Investor Presentation 9M 2014
2014-11-12 English
Biotest AG: Very good results of Civacir(R) (Hepatitis C Immune Globulin) US Phase III clinical trial
Regulatory Filings
2014-11-10 English
Biotest AG: Biotest receives marketing authorisation for Albiomin 20% in China
Regulatory Filings
2014-11-05 English
Biotest AG: Further preclinical studies emphasise the potential of Indatuximab Ravtansine (BT-062) in solid tumours
Regulatory Filings
2014-10-24 English
Biotest AG: Search at Biotest - company rejects allegations
Legal Proceedings Report
2014-10-15 English
Biotest AG: Search at Biotest - company rejects allegation
Legal Proceedings Report
2014-10-15 English
Biotest AG: Biotest completes recruitment in Phase IIb study (TREAT 2b) of Tregalizumab (BT-061) in patients with rheumatoid arthritis
Regulatory Filings
2014-09-09 English
DGAP-DD: Biotest AG english
Director's Dealing
2014-08-12 English
Call Transcript 2014
Call Transcript
2014-08-12 German
Call Transcript 2014
Call Transcript
2014-08-12 English
Q2 Report 2014
Interim / Quarterly Report H2 2014
2014-08-12 German
Biotest AG: Biotest increases revenues by 8,5%
Earnings Release H1 2014
2014-08-11 English
Biotest AG: Outlook revised
Earnings Release H1 2014
2014-08-11 English
Biotest AG: Dr. Bernhard Ehmer to become new CEO of Biotest AG
Board/Management Information
2014-07-09 English
Datum:20.06.2014
Notice of Dividend Amount
2014-06-20 German
Investor Presentation 2014
Investor Presentation
2014-06-02 German
Investor Presentation 2014
Investor Presentation
2014-06-02 English
DGAP-DD: Biotest AG english
Director's Dealing
2014-05-19 English
DGAP-DD: Biotest AG english
Director's Dealing
2014-05-08 English
Biotest AG: : Annual general meeting approves again increase of dividend
AGM Information
2014-05-07 English
Biotest AG: Biotest continues to show a sales increase
Earnings Release Q1 2014
2014-05-07 English
Q1 Report 2014
Interim / Quarterly Report Q1 2014
2014-05-07 German
Datum:29.04.2014
Annual Report FY 2013
2014-04-29 German
DGAP-DD: Biotest AG english
Director's Dealing
2014-03-31 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-03-28 English
Declaration of Voting Results & Voting Rights Announcements 2014
Declaration of Voting Results & Voting Rights Announcements
2014-03-27 English
Biotest AG: Biotest AG initiates clinical study with Indatuximab Ravtansine (BT-062) in solid tumors
Legal Proceedings Report
2014-03-27 English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 07.05.2014 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2014-03-26 German
Biotest AG: Biotest increases profit after tax by 38.5 %
Earnings Release FY 2013
2014-03-25 English
Magazine for Annual Report 2013
Annual Report FY 2013
2014-03-25 English
Annual Report 2013
Annual Report FY 2013
2014-03-25 German
Investor Presentation 2014
Investor Presentation
2014-03-25 English
Investor Presentation 2014
Investor Presentation
2014-03-25 German
Biotest AG: Biotest increases earnings after taxes by 38.5%
Earnings Release FY 2013
2014-02-20 English
Earnings Release 2013
Earnings Release FY 2013
2014-02-20 English
Management Reports 2014
Management Reports
2014-02-20 German